The RNA-binding protein Musashi-1 (Msi1) has been proposed as a marker of intestinal epithelial stem cells. These cells are responsible for the continuous renewal of the intestinal epithelium. Although the function of Msi1 has been studied in several organs from different species and in mammalian cell lines, its function and molecular regulation in mouse intestinal epithelium progenitor cells are still undefined. We describe here that, in these cells, the expression of Msi1 is regulated by the canonical Wnt pathway, through a mechanism involving a functional Tcf/Lef binding site on its promoter. An in vitro study in intestinal epithelium primary cultures showed that Msi1 overexpression promotes progenitor proliferation and activates Wnt and Notch pathways. Moreover, Msi1-overexpressing cells exhibit tumorigenic properties in xenograft experiments. These data point to a positive feedback loop between Msi1 and Wnt in intestinal epithelial progenitors. They also suggest that Msi1 has oncogenic properties in these cells, probably through induction of both the Wnt and Notch pathways.
Introduction
The intestinal epithelium is characterized by rapid and continuous renewal throughout life. This renewal process depends on multipotent stem cells located in the intestinal crypts (Stappenbeck et al., 1998) . These somatic stem cells self-renew by asymmetric division and give rise to undifferentiated progenitors that proliferate, differentiate while migrating, and are eventually shed in the lumen after apoptosis. In mice, this entire process lasts 3-4 days (Stappenbeck et al., 1998) . The continuous cell renewal and the homeostasis of the intestinal epithelium are regulated by several signaling pathways, such as the Wnt and Notch pathways (Korinek et al., 1998; van Es et al., 2005) . We have also shown that the thyroid hormone receptor TR1 participates in these processes (Plateroti et al., 2001; Kress et al., 2008) . The integration of these signals at the level of crypt progenitors has been shown to play an important role (Plateroti et al., 2006; Fre et al., 2009; Kress et al., 2009 ). However, it remains unclear whether these functional interactions also play a role in intestinal stem cell physiology, because only recently have robust markers for these cells been described (Montgomery and Breault, 2008) . Importantly, among them, Musashi-1 (Potten et al., 2003; Kayahara et al., 2003) is at the crossroads of the Wnt, Notch and thyroid hormone signaling pathways.
Musashi-1 (Msi1) is an RNA-binding protein, which acts as a translational regulator of target mRNAs, by competing with the translation initiation factor eIF4G (Kawahara et al., 2008) . Several studies have linked Msi1 with both stem cell and tumor biology, through its functional relations with signaling pathways. In neuronal precursors, Msi1 is involved in the control of 'stemness' by regulating the Notch pathway . Moreover, some data reported that Msi1 is regulated in mouse intestine by the Wnt pathway (Potten et al., 2003) and by thyroid hormones during metamorphosis in amphibians (Ishizuya-Oka et al., 2003) , as well as in rat neural precursors (Cuadrado et al., 2002) . Its involvement in stem cell physiology was first discovered through pioneer studies in Drosophila (Nakamura et al., 1994; Siddall et al., 2006; Okabe et al., 2001) . In mammals, Msi1 has been described as a marker of adult stem cells and progenitors in other tissues such as the central nervous system (Kaneko et al., 2000) , hair follicles (SugiyamaNakagiri et al., 2006) , and mammary glands (Clarke et al., 2005) . However, the role of Msi1 in the stem-cell-progenitor compartment has been described only in the nervous system (Sakakibara et al., 2002) .
Until recently, only two mRNA targets of Msi1 were known: mNumb, an antagonist of the Notch pathway that has been studied in neural progenitor cells , and p21/Waf1, described in the HEK293T cell line (Battelli et al., 2006) . de Sousa Abreu et al. (de Sousa Abreu et al., 2009) identified new mRNA targets of Msi1 in HEK293T cells. These mRNA targets are implicated in cell proliferation and protein modification, both of which are involved in tumorigenesis. Additional data reported the involvement of Msi1 in inducing cell proliferation in a mammary gland cell line (Wang et al., 2008) , as well as in the growth of a colon carcinoma cell line in xenograft experiments (Sureban et al., 2008) .
Taken together, these data indicate that Msi1 is important for stem cell biology in several systems. However, Msi1 is also related to several signaling pathways (i.e. Wnt, Notch, thyroid hormones) important for progenitor cell homeostasis, which is affected in intestinal tumorigenesis. We analyzed the physiological significance of these regulatory pathways as well as the function of Msi1 in intestinal epithelial progenitor cells. We show that the expression of Msi1 is regulated in a cell-autonomous way by the Wnt pathway. Lentiviral-mediated increase in the expression of Msi1, in turn, stimulates the Wnt pathway through the induction of Frat1, a potent activator of -catenin stabilization (Hay et al., 2005; van Amerongen et al., 2005) . Finally, we also show that Msi1 overexpression has the potential to induce tumor formation in a xenograft model.
Results

Regulation of Msi1 in intestinal epithelial cells
Msi1 expression has been shown to be induced in intestinal tumors that develop in Apc min/+ mice (Potten et al., 2003) , suggesting its potential regulation by the canonical Wnt pathway. First, we confirmed the induction of Msi1 mRNA expression in tumors from Apc 1638N/+ mice (Fig. 1A) , another model of intestinal tumorigenesis induced by the activation of Wnt (Fodde et al., 1994) . Indeed, a 4-to 5-fold increase in the levels of Msi1 mRNA was observed in tumors as compared to normal neighboring mucosa or wild-type intestine. This induction is comparable to that of cyclin D1 (Fig.  1A ) and Axin2 mRNA (data not shown), known targets of the canonical Wnt pathway (Wnt homepage, http://www.stanford.edu/ rnusse/pathways/targets.html). Next, we analyzed whether this regulation is epithelial-cell autonomous. For this, we treated intestinal epithelial primary cultures with the canonical Wnt3a ligand (Kengaku et al., 1998) . mRNA levels of cyclin D1 (Fig. 1B ), Axin2 and CD44 (not shown), used as positive controls, were significantly higher in treated as compared with control cells. Msi1 mRNA expression was slightly but significantly upregulated by Wnt3a (Fig. 1B) . This regulation was confirmed at the protein level by western blot analysis (Fig.  1C ) and by immunolabeling (Fig. 1F,I ). The increased levels of activated -catenin (Fig. 1C ) and the increased number of cells displaying nuclear staining for -catenin (Fig. 1E,H) confirmed the efficiency of Wnt3a treatment. Interestingly, we could correlate the increased expression of Msi1 with the downregulation of p21, one of its known targets (Fig. 1C) (Battelli et al., 2006) . Regulation of Msi1 mRNA expression by the Wnt pathway was also confirmed by treating the primary cultures with the antagonist Dkk4 (Krupnik et al., 1999) (supplementary material Fig. S1A ). Since activation of the Wnt pathway in intestinal progenitors induces cell proliferation, we analyzed BrdU incorporation in primary cultures maintained in different experimental conditions. The addition of Wnt3a to the culture medium induced an increased number of BrdU-positive nuclei, as compared with the control cells (Fig. 1G,D) . In Dkk4-treated cells, the numbers of BrdU-, nuclear -catenin-and Msi1-positive cells (supplementary material Fig. S1B-D) were similar to those observed in control cells (Fig.  1D-F) .
Msi1 expression has been shown to be induced by thyroid hormone (TH) in the intestine of Xenopus laevis during metamorphosis (Ishizuya-Oka et al., 2003) , as well as in rat neuronal cell lines (Cuadrado et al., 2002) . When we tested whether Msi1 could also be regulated by TH in the mouse intestine, we observed a positive regulation in vivo (supplementary material Fig. S2A ), but not in vitro in primary cultures (supplementary material Fig. S2B) .
Altogether, these data show that Msi1 expression is positively regulated by the canonical Wnt pathway, and that this process is epithelial-cell autonomous.
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Study of Msi1 promoter regulation
By in silico analysis, using MathInspector software (Genomatix), we identified a putative thyroid hormone receptor binding site (DR4) and two putative Tcf/Lef binding sites (responsive to Wnt activation) within the same region, located 6 kb upstream of the Msi1 coding sequence (supplementary material Fig. S3A ). A short (0.9 kb) and a large (7 kb) fragment of the Msi1 promoter were cloned in a luciferase reporter vector, named pMsi1-1-Luc and pMsi1-7-Luc, respectively (supplementary material Fig. S3B ). Modulation of the transcriptional activity of both constructs by Wnt signaling was tested in Cos7 cells. TopFlash and FopFlash reporter vectors were used as positive and negative controls, respectively. Cotransfection of TopFlash and expression vectors coding for -catenin and Tcf1, nuclear effectors of the canonical Wnt pathway, lead to a 4-fold increase in luciferase activity ( Fig.  2A) . As expected, Fopflash activity did not change in the different experimental conditions (Fig. 2B) . Interestingly, cotransfection of pMsi1-7-Luc together with -catenin and Tcf1 expression vectors led to a 4-fold increase in luciferase activity, whereas pMsi1-1-Luc did not respond to -catenin and Tcf1 overexpression ( Fig. 2A) . Moreover, a dominant negative form of Tcf1 (DNTcf), in the presence of the wild-type Tcf1, abolished the induction of the luciferase activity on both TopFlash and pMsi1-7-Luc.
To identify the roles of the two putative Tcf/Lef binding sites present in the Msi1 promoter, we subcloned each of them upstream of a luciferase reporter system. These constructs, as well as the specific mutants, were used in cotransfection experiments (Fig.  2C) . Interestingly, only the site1 construct (Msi1-s1) was induced 3258 Journal of Cell Science 123 (19) by cotransfection with -catenin and Tcf1 vectors. This regulation was blunted when the same site was mutated (Msi1-s1m).
Taken together, these data show that Msi1 expression is regulated by the Wnt--catenin pathway in intestinal epithelial cells, likely through the functional Tcf/Lef binding site Msi1-s1 located in the promoter region.
Similar experiments, aimed to evaluate the responsiveness of the Msi1 promoter to TH-TR1, clearly indicated that this promoter is unresponsive to the thyroid hormone-dependent signal (supplementary material Fig. S2C ).
Overexpression of Msi1 cDNA in intestinal epithelial primary cultures
Several studies explored the function of Msi1 in tumor cell lines (Sureban et al., 2008; Wang et al., 2008) . We decided to investigate its function in intestinal epithelial progenitor cells in a non-tumoral ex vivo primary culture model. First, we overexpressed Msi1 in intestinal epithelial primary cultures using lentiviral infection. Intestinal epithelial cells were infected using GFP (I-GFP)-or Msi1 (I-Msi1)-coding viral particles. Msi1 overexpression was confirmed by RT-qPCR (Msi1CDS; Fig. 3A ), immunofluorescence ( Fig. 3C ) and western blot analysis (Fig. 3F ). It is worth noting that overexpression of Msi1 had no effect on the expression of endogenous Msi1 mRNA (Msi1UTR; Fig. 3A ).
Given that Msi1 is a putative marker of intestinal epithelial stem cells, we analyzed the effect of Msi1 overexpression on the expression of Lgr5 and Bmi1, established markers of those cells (Barker et al., 2007; Sangiorgi and Capecchi, 2008) . Interestingly, both mRNAs were significantly increased in Msi1-infected cells compared with the control cells (supplementary material Fig. S4 ). Next, we wondered whether Msi1 overexpression could have an effect on the expression of genes involved in stem cell physiology. For this investigation, we used the PCR array mouse stem cell approach (SABiosciences), on RNA extracted from Msi1-or GFPinfected cells. The results of this analysis showed only a very limited number of deregulated mRNAs in Msi1-overexpressing cells. However, we confirmed that the expression of cell cycle regulators can be affected by Msi1 (supplementary material Table  S1 ), in accordance with a previous report (Wang et al., 2008) . More importantly, our data also showed that Frat1 mRNA was significantly increased by Msi1 overexpression, as compared with the level in the control cells. Interestingly, Frat1 is known to be a potent activator of the canonical Wnt pathway (Hay et al., 2005) . This protein is dispensable with regard to Wnt--catenin signaling, but it can enhance the accumulation of activated -catenin (van Amerongen et al., 2005) . We first validated Frat1 upregulation by conventional RT-qPCR on I-Msi1 as compared with control I-GFP cells (Fig. 3A) . We also showed that Frat1 protein expression, analyzed by immunostaining and western blot, was clearly increased in Msi1-overexpressing cells (I-Msi1) as compared with control cells (Fig. 3D-F ).
Msi1 induces cell proliferation and activates Wnt--catenin and Notch signaling pathways
Our data on the stimulation of Msi1 expression by Wnt3a, together with the results of the PCR arrays, clearly suggested a link between Msi1 and cell proliferation. We then quantified the proliferation rate of I-Msi1 as compared with the control I-GFP cells by counting BrdU-positive nuclei under the microscope (Fig. 4) . Msi1-overexpressing cells showed a significant 3-to 4-fold increase in the number of BrdU-positive nuclei as compared with I-GFP In addition, Renilla luciferase expression vector (pRL-TK vector; Promega) was used to normalize the firefly luciferase content in each sample. TopFlash vector (Upstate) was used as a positive control for Tcf--catenin activation. FopFlash (B) vector (Upstate) was cotransfected into Cos7 cells as a negative control. Values are means ± s.d., from three independent experiments, each conducted on six replicates (n18). (C)Cotransfection experiments with different luciferase constructs performed in Cos7 cells to identify the functionality of the putative Tcf/Lef sites. Luciferase constructs with the Msi1 site1 (Msi1-s1) and Msi11 site2 (Msi1-s2), wild type and mutated (Msi1-s1m, Msi1-s2m) were used. TopFlash and FopFlash were used as positive and negative controls, respectively. Values are means ± s.d., from two independent experiments, each conducted on six replicates (n12) **P<0.01, ***P<0.001, by two-tailed Student's t-test.
control cells (Fig. 4C) . Apoptosis, analyzed by immunostaining for cleaved caspase 3, did not vary among the different experimental conditions (data not shown).
Msi1 was previously shown to activate the Notch pathway in neural precursors . Moreover, our data on Msi1-dependent induction of Frat1 expression led us to analyze the Wnt and Notch pathways in intestinal epithelial primary cultures infected with Msi1. With regard to Notch, we observed that the intracellular domain of the Notch-1 receptor (NICD), analyzed by western blot, was upregulated in Msi1-infected cells as compared with control cells (Fig. 5A) . Moreover, immunolabeling for Hes1, a known target of NICD (Jarriault et al., 1995) , showed a strong increase in the number of cells displaying nuclear Hes1 in Msi1-overexpressing cells (Fig. 5D,C) . Increased levels of both NICD and Hes1 reflect the activation of Notch pathway. With regard to Wnt, infection with Msi1 clearly induced an increase in activated -catenin compared with the level in I-GFP cells (Fig. 5A ). Immunostaining analysis also showed an increased number of cells exhibiting nuclear -catenin in I-Msi1, as compared with control cells (Fig.  5F,E) . Interestingly, I-Msi1 cells also showed increased levels of the Wnt--catenin targets Myc, cyclin D1 and cyclin D2 (Fig. 5B) , all positive regulators of cell proliferation (He et al., 1998; Tetsu and McCormick, 1999; Kioussi et al., 2002) . The increased number of cyclin-D1-positive nuclei is also clearly illustrated by immunofluorescence (Fig. 5H,G) . Finally, reduced protein levels of the cell cycle inhibitor p21 were also observed in I-Msi1 cells (Fig. 5B) , probably due to the translational repression by Msi1 (Battelli et al., 2006) and/or transcriptional repression by Myc (Gartel and Radhakrishnan, 2005) .
To test the hypothesis that the Msi1-dependent increased expression of Frat1 was responsible for the Wnt--catenin activation, we used an approach of ShRNA to knockdown Frat1 expression in I-Msi1 cells. The efficiency of two independent short-hairpin constructs on Frat1 mRNA expression is illustrated in supplementary material Fig. S5A . This result was also confirmed at the protein level by the scoring of Frat1 immunolabeled cells in different experimental conditions (Fig. 6A-C,J) . Interestingly, we observed that by infecting the I-Msi1 cells with ShRNAs against Frat1, we reduced the number of cells expressing nuclear -catenin when compared with the cells infected only with Msi1 or with an ShRNA negative control (Fig. 6D-F,K) . Moreover, the decrease of -catenin-expressing nuclei was parallel to the decrease of cyclin-D1-expressing nuclei (Fig. 6G-I,L) . Finally, the ShRNAs against Frat1 had no effect on the number of Msi1-or Hes1-expressing cells (supplementary material Fig. S5B ).
Taken together, these data show that Msi1 overexpression in intestinal epithelial primary cultures enhances their proliferative status and induces both the Wnt--catenin and Notch signaling pathways. We also demonstrated that the induction of Wnt depends on the previous upregulation of Frat1.
Injection of IEC6-Msi1 cells in immunodeficient mice
Msi1 is known to be overexpressed in different tumors, including intestinal tumors in a mutated Apc background (Potten et al., 2003) (Fig. 1A) . Moreover, its downregulation has been correlated with a reduction of tumor growth (Sureban et al., 2008) . However, these data were related to established pathological conditions (i.e. tumors or tumor cell lines). No studies have reported that Msi1 exhibits potential tumorigenicity in normal intestinal epithelial cells.
To test this possibility, we used the rat intestinal crypt-derived cell line IEC6, which are untransformed cells retaining most of their original characteristics (Quaroni et al., 1979) . IEC6 cells were stably transduced with GFP-or Msi1-coding viral particles. In those cells, as in the primary cultures, Msi1 overexpression activates Wnt and Notch pathways, as assessed by immunolabeling for -catenin and Hes1 (supplementary material Fig. S6 ). Next, both cell lines were used for xenograft experiments on BALBc/nude mice. Two independent series of cell injections, including three controls (IEC6-GFP), and injection of seven mice with IEC6-Msi1, were performed. For mice injected with control cells, we did not detect any graft growth (example in Fig. 7A ), in accordance with the non-tumorigenic properties of this cell line (Buick et al., 1987) . We also confirmed the absence of IEC6-GFP cells by recovering some subcutaneous biopsies at the sites of the injections and at other areas (not shown). By contrast, injections of IEC6-Msi1 cells induced the development of xenografts growing at the original site of injection in all mice (example in Fig. 7B-D) . These samples were collected and used for histological and immunofluorescence analyses. Within the grafts, the IEC6-Msi1 cells frequently organized around a lumen-like structure (Fig.  8A-C) . In some cases, polarized epithelial cells with basal nuclei were clearly visible (Fig. 8D) . As expected, these cells expressed Msi1, as revealed by immunofluorescence (Fig. 9A) , and had an epithelial phenotype, as assessed by cytokeratin labeling (Fig.  9D,E) . Moreover, they expressed high levels of -catenin, sometimes with a clear nuclear localization (Fig. 9B,C) . These cells also expressed cyclin D1 (Fig. 9F) and Hes1 (Fig. 9H,I ), reflecting the activation of both Wnt and Notch pathways. Finally, the IEC6-Msi1 cells were actively proliferating, as assessed by Ki67 immunolabeling (Fig. 9G ).
Discussion
The intestinal epithelial stem cells are responsible for the continuous and rapid renewal of this tissue. It is known that these cells are located in the crypts of Lieberkhün, but their identification and characterization have been controversial. However, it has become clear that there exist two populations of intestinal stem cells. One population is composed of columnar basal cells (CBC), at the very bottom of the crypts, between Paneth cells in the small intestine. This population cycles actively, specifically express the Lgr5 marker and can give rise to the different cytotypes of the intestinal epithelium (Barker et al., 2007) . The second population is composed of quiescent stem cells, located at the +4 position, expressing Bmi1 (Sangiorgi and Capecchi, 2008) . This population also gives rise to all epithelial cytotypes, but the cells are slow cycling, and 3261 Musashi-1 in the intestinal epithelium retain labeling. Interestingly, the RNA-binding protein Msi1 has been described as a putative intestinal stem cell marker for both populations (Potten et al., 2003; Kayahara et al., 2003) . This protein is known to be involved in the regulation of asymmetric division, cell fate decisions and stem cell maintenance in Drosophila (Nakamura et al., 1994; Okabe et al., 2001; Siddall et al., 2006) . In mammals, Msi1 is an adult stem cell marker in different organs, suggesting its potential role in adult stem cell physiology. However, the function of Msi1 in somatic stem cells, apart from those of the nervous system , and in particular of the intestinal epithelium, remain undefined. We show here, in an in vitro model, that Msi1 is involved in the proliferative capacities of the intestinal epithelial progenitors. This occurs as a result of Msi1-dependent activation of both Wnt and Notch pathways in Msi1-overexpressing cells, which probably maintains the cells in a 'progenitor state'. This is in accordance with recent observations in the Drosophila developing eye (Fre et al., 2009) .
It is clear that Msi1 is at the crossroads of several signaling pathways that are important in intestinal development and homeostasis. However, a detailed analysis of these multiple regulations in the same physiological model was lacking. We sought to construct a unified model. Indeed, we showed that the thyroid hormones regulate the expression of Msi1 in the mouse intestine, as previously demonstrated in amphibians (Ishizuya-Oka et al., 2003) . In accordance with the paper by Ishizuya-Oka et al. (Ishizuya-Oka et al., 2003) , we also observed that this regulation is not epithelial autonomous. Finally, given that the Msi1 promoter is not regulated by TH-TR1, we conclude that this control is indirect. However, supplementary studies are necessary to clearly define the mechanism by which TH modulates Msi1 levels. Msi1 expression is upregulated in intestinal tumors from Apc-mutant mice (Potten et al., 2003) , suggesting its possible regulation by the Wnt pathway. We confirmed this finding in the present study and extended the observation by analyzing Msi1 expression in intestinal tumors from the Apc 1638N/+ mice, another Apc-mutant mouse model, and in an in vitro model of primary cultures. Furthermore, we dissected the mechanism responsible for the activation of Msi1 expression by the Wnt pathway. In fact, we identified a functional Tcf/Lef binding site located in the promoter of Msi1, at -6 kb from the start site. It is worth noting that previous studies using 4.5 kb of the Msi1 mouse promoter failed to demonstrate its direct control by -catenin-Tcf (Keyoung et al., 2001; Kanai et al., 2006) . This is not in contradiction with our results, because we showed that the Tcf/Lef binding site is outside the portion of the promoter that was used by these authors. Msi1 is an RNA-binding protein that represses mRNA translation by binding specific consensus sites present in the 3Ј-UTR region of its targets . In fact, Msi1 competes with the translation initiation factor eIF4G to bind PABP, preventing the initiation of translation (Kawahara et al., 2008) . A recent study identified new direct targets of Msi1 using a global RIP-Chip analysis (de Sousa Abreu et al., 2009 ). The authors showed that these targets preferentially participate in two major processes involved in tumorigenesis: proliferation versus apoptosis, and protein modifications. Another study described several mRNAs that are deregulated by Msi1 overexpression, which are therefore considered to be indirect targets (Wang et al., 2008) . Interestingly, this study showed that the overexpression of Msi1 in a mammary cell line induces cell proliferation and activates Wnt and Notch pathways. Here we report similar results in a different cellular context. Indeed, we show that Msi1 overexpression increases the proliferative capacity of epithelial progenitors in vitro. More importantly, and in accordance with the previous study on the mammary cell line, we also described the joint induction of Wnt and Notch pathways. These results, therefore, point to a general mechanism of action of Msi1.
The mechanism at the basis of the Msi1-dependent activation of the Wnt pathway in our model system is probably due to enhanced expression of Frat1. This is the first report describing the regulation of Frat1 by Msi1. Frat1 is known to be a potent activator of the canonical Wnt signaling pathway, since it interacts with GSK3 and Dvl proteins and enhances Lef-mediated transcription (Li et al., 1999) . Accordingly, we showed that the increased expression of Frat1 mediated by Msi1 stabilizes -catenin and increases levels of its targets, cyclin D1 and Myc. It is worth noting that the study on the mammary cell line described a different mechanism for Msi1 activation of the Wnt pathway, dependent on decreased expression of Dkk3 (Wang et al., 2008) . Even if we can suppose a generalized mechanism of action of Msi1 in stem and/or progenitor cells, our data suggest that cell-context specificities need to be taken into account. Finally, concerning Notch activation in Msi1-overexpressing cells, our results show increased levels of Notch NICD and Hes1. Because of the recent data describing Notch activation by Wnt in colorectal cancer cells (Rodilla et al., 2009) , it was possible that, in our model, the increased Notch activity was secondary to that of Wnt. However, we have shown that this is not the case. In fact, blocking the Wnt activation by Frat1 knockdown in I-Msi1 cells has no effect on Hes1 expression. These data clearly show that Notch activation in Msi1-overexpressing cells is independent of Wnt activity. Hence, the pattern we observe might be due to the direct translational repression of mNumb, as has been reported for neural precursors . Taken together, these results show that Msi1 overexpression enhances the proliferative capacities of intestinal progenitors through concomitant induction of Wnt and Notch pathways. Moreover, we identified Frat1, an activator of -catenin signaling, as an intermediate target responsible for the Msi1-dependent activation of Wnt.
Different studies have shown that a deregulation of the canonical Wnt pathway leads to intestinal tumorigenesis (Moser et al., 1990; Fodde et al., 1994) . Moreover, Wnt and Notch pathways act in synergy to promote colorectal cancer (Fre et al., 2009; Rodilla et al., 2009) . Notably, increased levels of Msi1 have been clearly demonstrated in several tumors, such as gliomas (Toda et al., 2001) , endometrial tumors (Götte et al., 2008) and intestinal tumors (Potten et al., 2003) . This observation suggests that Msi1 overexpression, which induces both Wnt and Notch pathways, might have tumorigenic potential. In fact, we show here that Msi1 overexpression induces subcutaneous tumor development. This induction was clearly associated with increased proliferative capacity within the xenografts. However, it is worth noting that such a regulatory loop is achieved through high Msi1 overexpression. Further investigation will be necessary to define whether a precise correlation exists between Msi1-overexpression levels and specific cellular responses.
These data demonstrate the tumor-inducing potential of Msi1 in normal intestinal epithelial cells and suggest that deregulated expression of Msi1 could be an early event associated with intestinal tumorigenesis. In fact, it has been suggested that Frat1 could be recruited to activate -catenin-Tcf-dependent transcription when the physiological balance between proliferation and differentiation is disrupted (Ruiz et al., 2004) . Increased expression of Frat1 in Msi1-overexpressing cells could then reflect a pathological state linked to the tumor-inducer role of Msi1 described here. Our data are in agreement with recent reports that intestinal epithelial stem cells are at the origin of intestinal carcinogenesis (Sangiorgi and Capecchi, 2008; Barker et al., 2009) . Two previous studies linked the level of Msi1 expression to human colorectal carcinomas in patients (Fan et al., 2009) and in an ex vivo study (Sureban et al., 2008) . Our results confirm this link and elucidate the function of Msi1 in early cell transformation events leading to tumorigenesis.
Materials and Methods
Animals and tissue preparation
We used Apc 1638N/+ and wild-type animals in this study. Mice were housed and maintained with approval from the animal experimental committee of the Ecole Normale Supérieure de Lyon (Lyon, France) and in accordance with European legislation on animal care and experimentation. Thyroid hormone (TH) deficiency in pups was induced by feeding the mothers a low-iodine diet supplemented with 0.15% propylthiouracil (PTU; Harlan/Teklad) for 2 weeks. Hyperthyroidism was induced by intraperitoneal injections of a mixture of T4 and T3 (one daily injection for two days of 2.5 mg/kg T4 and 0.25 mg/kg T3 in 100 l of phosphate-buffered saline) to PTU-feed animals. Control animals were fed standard mouse chow. Animals were killed at the indicated ages, and the intestine was quickly removed. Samples were frozen in liquid nitrogen and used later for RNA extraction.
Primary cell cultures of intestinal epithelial cells
Intestinal epithelial primary cultures were derived from 4-to 6-day-old neonatal mice. Briefly, after sacrifice, the entire small intestine was removed. The epithelium was isolated as intact organoids by enzymatic dissociation using collagenase type XI (Sigma) and dispase (Boehringer Mannheim), followed by physical disaggregation and filtration on gauze. Organoids were plated in Dulbecco's modified Eagle medium (DMEM; Invitrogen) supplemented with 2.5% heat-inactivated fetal calf serum (Gibco), 20 ng/ml epidermal growth factor (Sigma), and insulin-transferrin-selenium diluted 1:100 (Sigma). Culture surfaces were coated with Matrigel TM Basement Membrane Matrix (BD Biosciences). For immunolabeling experiments, coverslips were inserted in the wells before coating. For proliferation studies, 10 M BrdU was added to the culture medium for an overnight incubation. The purity of the epithelial colonies was analyzed by immunolabeling for specific markers: anti-cytokeratins (ICN) for epithelial cells; anti-vimentin (Sigma) for fibroblasts; anti-smooth muscle actin (Sigma) for smooth muscle cells (supplementary material Fig. S7 ). For treatment experiments, after 2 days of culture, recombinant Wnt3a or Dkk4 was added to the culture medium for 24 hours.
Lentiviral infections
For overexpression experiments, cells were infected with lentiviral particles. Lentiviral vectors expressing GFP or Msi1 were obtained from the Vectorology Facility at IFR128 Lyon-Biosciences. GAE-SFFV-GFP is an SIV-derived lentiviral vector expressing GFP (a gift from Els Verhoeyen, INSERM U758, Lyon, France). GAE-SFFV-Msi1 vector was obtained by cloning Msi1 cDNA into GAE-SFFV-GFP after removal of GFP cDNA. After 2 days in culture, viral supernatant in epithelial medium (1:1) was used to infect intestinal epithelial cells, for 48 hours or 96 hours. GAE-SFFV-GFP vector was used to produce control lentiviral particles. For ShRNA experiments, primary cultures were first infected with GAE-SFFV-Msi1 or GAE-SFFV-GFP vectors. 48 hours after the first infection, cells were infected with Sh viral supernatant in epithelial medium (3:2) for 96 hours. ShRNA lentiviral vectors were Mission-shRNA (derived from pLKO.1-puro; Sigma). Lentiviral particles expressing Sh SC (scrambled control), Sh 30 and Sh 32 (targeting Frat1 mRNA) were obtained from the Vectorology Facility at IFR128 Lyon-Biosciences.
Cells were washed twice with phosphate-buffered saline and frozen at -80°C for RNA or protein extraction, or alternatively, fixed in 2% paraformaldehyde for immunostaining experiments.
RNA extraction and analysis
RNA was extracted from tissue samples using the Qiagen RNeasy kit (Qiagen). To avoid the presence of contaminating DNA, DNase digestion was performed on all preparations. Reverse transcription was performed using MuMLV reverse transcriptase (Promega) on 1 g of total RNA according to the manufacturer's instructions, using random hexanucleotide priming (Promega). For primary cultures, RNA was extracted using the Absolutely RNA Nanoprep Kit (Stratagene). Reverse transcription was performed using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen) on 300 ng of total RNA. All cDNA samples were purified using the Qiagen PCR purification kit (Qiagen) before use for qPCR experiments. qPCR analyses were performed with SYBR green PCR master mix (Qiagen) in an MxP3000 apparatus (Stratagene). The data from the qPCR were normalized to 36B4 levels in each sample. Primer sequences are shown in supplementary material Table  S2 or in van der Flier et al. (van der Flier et al., 2009 ) and Kress et al. (Kress et al., 2010) .
Immunostaining and western blot
Immunolabeling of primary intestinal epithelial cells was performed on 2% paraformaldehyde-fixed cultures. Paraffin sections (5 m thickness) of xenografts were used for indirect immunostaining. Briefly, sections were deparaffinized in methylcyclohexane for 10 minutes, hydrated in ethanol, and washed with PBS. Slides were then subjected to antigen retrieval, using microwave heating in 0.01 M citrate buffer (pH 6), and incubation for 1 hour at room temperature with blocking buffer (10% normal goat serum, 1% BSA, and 0.02 Triton X-100 in PBS). The slides or coverslips were incubated with primary antibodies overnight at 4°C, followed by incubation with fluorescent secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). All nuclei were stained with Hoechst (Sigma). Fluorescence and bright-field microscopy were performed on a Zeiss Axioplan microscope (Carl Zeiss).
Protein extracts were obtained by homogenizing intestinal epithelial cells in RIPA buffer (50 mM Tris, pH 7.4; 150 mM NaCl; 1 mM phenylmethylsulfonylfluoride; 1 mM EDTA; 5 g/ml aprotinin; 5 g/ml leupeptin; 1% Triton X-100; 1% sodium deoxylate; 0.1% sodium dodecyl sulfate; 40 l/ml protease inhibitors). Proteins were separated on 8 or 10% acrylamide-bis acrylamide (29:1) gel and transferred to a nitrocellulose membrane (Hybond ECL, Amersham) before saturation and incubation with the first antibody. This was followed by incubation with secondary antibodies (Promega). The signal was analyzed using the enzymatic chemiluminescence detection kit (LumiLight; Roche Clinical Laboratories).
We used the following primary antibodies: anti-activated -catenin (Upstate); anti--catenin (Santa Cruz); anti-Musashi-1 (Chemicon and Abcam); anti-Notch1-NICD (Cell Signaling); anti-p21 (Santa Cruz); anti-Frat1 (Santa Cruz); anti-cyclinD1 (LabVision); anti-cyclinD2 (Sigma); anti-Ki67 (Labvision); anti-c-myc (Santa Cruz); anti-Hes1 (MBL).
Construction of pMsi1-Luc vectors
Msi1 promoters were amplified from BAC clone RP24-243N1 (BACPAC Resources Center, CHORI, Oakland, CA). Briefly, a 900 bp fragment was amplified at the 5Ј end of the Msi1 start codon and cloned in pGL3 vector (Promega) to construct the pMsi1-1-Luc vector. A 6 kb distal fragment was added into pMsi1-1-Luc to obtain the pMsi1-7-Luc construct, using the SpeI site (scheme in supplementary material Fig. S3 ). Msi1s1wt-Luc, Msi1s1Mut-Luc, Msi1s2wt-Luc and Msi1s2Mut-Luc constructs were obtained by cloning a 20-bp sequence corresponding, respectively, to Msi1-Tcf/Lef putative binding site1 wild-type (5Ј-TGGGAGTTC -TTTGAAACACACG-3Ј), site1 mutated (5Ј-TGGGAGTTCTTTGGGACACACG-3Ј), site2 wild-type (5Ј-TGGG CGGATCTTTGAATTCGAGG-3Ј), and site2 mutated (5Ј-TGGGCGGATCTTTG GGTTCGAGG-3Ј). These were cloned upstream of the TK minimal promoter of the TopFlash backbone (Upstate) using NdeI-BamHI restriction enzymes, after removal of the Tcf/Lef sites.
Cell lines culture and transfection experiments
Cos7 cells and IEC6 cells were cultured in DMEM supplemented with 5% heatinactivated fetal calf serum. pGl2-DR4-Luc vector, TopFlash vector (Upstate), FopFlash vector (Upstate), pMsi1-Luc vectors, pCIneo--cateninXL vector, Evr2-Tcf1E vector or Evr2-DN-Tcf1E vector were transfected into Cos7 cells using the Exgen transfection reagent (Euromedex). For T3 treatments, the cells were maintained, after transfection, in thyroid hormone-depleted serum. T3 (10 -7 M) or vehicle alone was added to the culture medium 24 hours before the end of the culture. Luciferase activity was measured 48 hours after transfection using the luciferase dual system (Promega). IEC6-GFP and IEC6-Msi1 cell lines were obtained by lentiviral infection of IEC6 cells, using GAE-SFFV-GFP-or GAE-SFFV-Msi1-derived viral particles.
PCR arrays
RNA extracted from cells that had been infected for 2 days were used with the PAMM-405A RT 2 Profiler TM PCR Array Mouse Stem Cell system (SABiosciences). Then 500 ng of RNA were retrotranscribed using the RT 2 First Strand Kit (SABiosciences) according to the manufacturer's protocol. RT-PCR array was performed using RT 2 qPCR Master Mix (SABiosciences) in an Mx3000P apparatus (Stratagene). Results were analyzed with SABiosciences software available at: http://www.sabiosciences.com/rt_pcr_product/HTML/PAMM-405A.html.
Xenograft experiments
We used 4-5 week-old athymic (BALB/c nu/nu) female mice. Tumorigenicity was assayed by subcutaneous dorsal injections of 3-4ϫ10 6 IEC6-GFP or IEC6-Msi1 cells resuspended in 50 l of IEC6 culture medium mixed with 50 l of matrigel (BD Biosciences). Animals were killed 6 weeks after cell inoculation, and grafts were removed, fixed in 4% paraformaldehyde and then embedded in paraffin for histological analysis.
